NASDAQ · Drug Manufacturers - Specialty & Generic

COLL (COLL) Stock

$24.30 +1.25% NASDAQ: COLL Healthcare

Valuation

MetricValue
Price$24.30
Market Cap$788.14M
P/E Ratio16.45
P/B Ratio2.62
P/S Ratio1.01
EPS (TTM)$0.00
52-Week High$50.79
52-Week Low$24.00
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE15.96%
ROA2.24%
ROCE10.25%
Gross Margin89.17%
Operating Margin15.96%
Net Margin5.93%
Debt/Equity2.75
Current Ratio1.71

Annual Financials (USD)

Metric20212022202320242025
Revenue$277.0M$464.0M$567.0M$631.0M$781.0M
Operating Profit$18.0M$33.0M$167.0M$170.0M$187.0M
Net Profit$72.0M$-25.0M$48.0M$69.0M$63.0M
EPS$1.86$-0.74$1.29$1.86$1.73
Op Margin6.4%7.2%29.5%26.9%24.0%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$692.0M$1.2B$1.1B$1.7B$1.7B
Total Liabilities$489.0M$979.0M$948.0M$1.4B$1.4B
Cash$186.0M$174.0M$239.0M$71.0M$251.0M
Borrowings$259.0M$709.0M$674.0M$859.0M$941.0M

Latest News

COLL: Lowering target price to $33.00 Argus Research · Jul 15, 2026 Should Value Investors Buy Collegium Pharmaceutical (COLL) Stock? Zacks · Jul 9, 2026 4 Defensive Stocks to Take Refuge in as Tech Sell-off Continues Zacks · Jul 8, 2026 1 Small-Cap Stock Worth Your Attention and 2 That Underwhelm StockStory · Jul 7, 2026 1 Mooning Stock to Own for Decades and 2 That Underwhelm StockStory · Jul 3, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$104.0M$124.0M$275.0M$205.0M$329.0M
Investing Cash Flow$-4.0M$-575.0M$-71.0M$-289.0M$-65.0M
Financing Cash Flow$-39.0M$-6.0M$-74.0M$-68.0M$-46.0M
Net Cash Flow$12.0M$-13.0M$64.0M$-143.0M$156.0M
Free Cash Flow$102.0M$123.0M$274.0M$203.0M$328.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.55
EV / EBITDA2.63
FCF Yield40.21%
Quick Ratio0.84
Interest Coverage0.98
Return 1Y9.81%
Return 3Y57.48%
Return 5Y48.89%

Ownership

Insiders Held1.16%
Institutions Held128.08%
Institutions Float Held129.58%
Institutional HolderSharesReport Date
Blackrock Inc.5,134,0272026-03-31
Janus Henderson Group PLC1,825,6512026-03-31
Invesco Ltd.1,591,9092026-03-31
Fuller & Thaler Asset Management Inc.1,499,5842026-03-31
Renaissance Technologies, LLC1,469,4492026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AMPH $23.74 +3.40% 12.02 $1.05B 0.00%
ATAI $7.35 +0.14% -8.44 $2.72B 0.00%
CRON $3.24 -4.14% -131.00 $1.21B 0.00%
DVAXDynavax Technologies Corporation $15.50 +0.00% -40.79 $1.82B 0.00%
GDRX $3.45 -0.29% 28.44 $1.20B 0.00%

About COLL

COLL is led by CEO Vikram Karnani, employs 357 people, headquartered in US, publicly traded since 2015.

COLL stock trades at $24.30 with a market capitalization of $788.14M. The stock is valued at a price-to-earnings (P/E) ratio of 16.45, price-to-book of 2.62, price-to-sales of 1.01. Over the past 52 weeks the stock has ranged between $24.00 and $50.79, and currently trades 52.2% below its 52-week high.

On profitability, COLL generates a return on equity (ROE) of 15.96%, above the typical market average, return on capital employed of 10.25%, an operating margin of 15.96%, a net profit margin of 5.93%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides